주식회사 넥스아이
NEX-I, Inc.
- 연구개발업
- 서울특별시 송파구
- 기타
- 직원 40명(국민연금 2026-08)
- 설립 2021년
NEX-I is currently aiming to develop the first new drug that overcomes tumor resistance to immunotherapy.
NEX-I, Inc.
NEX-I is currently aiming to develop the first new drug that overcomes tumor resistance to immunotherapy.